Surgery in North Huntingdon, PA

3 verified surgery doctors in North Huntingdon.

General surgeons perform operations across the abdomen, digestive tract, skin, and soft tissue.

NPPES tenure ≠ clinical experience. "Years on NPPES" is time since the physician first registered a National Provider Identifier, not time practicing medicine. Verify current license status with the state medical board.

Verify a license at the Pennsylvania State Board of Medicine

Dr. Geoffrey Joseph, MD

Surgery

21 yrs NPPES

NPI 1205825395

8775 NORWIN AVE, SUITE C, North Huntingdon, PA 15642(724) 765-1163

NPPES public registry

CMS Open Payments· No payments in 2023

Industry Payments

No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.

Dr. Sharon Goldstein, MD

Surgery

20 yrs NPPES

NPI 1609849587

8775 NORWIN AVE STE C1, North Huntingdon, PA 15642(724) 850-3150

NPPES public registryAccepts Medicare (2024)

CMS Open Payments· $295.68 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$295.68

Total received

Transactions

Paying companies

Top paying companies

Myriad Genetic Laboratories, Inc.$253.75

Tactile Systems Technology Inc$23.27

Novo Nordisk Inc$18.66

Among the 39,537 surgery doctors we've analyzed, about 52% received any industry payment (median $305 among those who did). This doctor's total ranks around the 73th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US surgery doctors.

Payments to Sharon Goldstein do not imply any wrongdoing. Many are meals, education, or research support.

Dr. Krishna Jetti, MD

Surgery

20 yrs NPPES

NPI 1740297399

12279 ROUTE 30, STE 200, North Huntingdon, PA 15642(724) 864-4470

NPPES public registry

CMS Open Payments· No payments in 2023

Industry Payments

No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.